Schedule 13G ownership disclosure
Aldeyra Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 01438T106
Event date: 2025-04-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 4,875,851 · Class: 8.2%
- Joseph Edelman
Shares: 4,875,851 · Class: 8.2%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 4,875,851 · Class: 8.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-051722
- Form type
- SCHEDULE 13G/A
- Filer
- Aldeyra Therapeutics, Inc.
- CIK
- CIK 1341235
- Filed
- Apr 07, 2025
- Reporting period
- Apr 03, 2025
- Description
- Schedule 13G beneficial ownership